utreloxastat (PTC857) / PTC Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
utreloxastat (PTC857) / PTC Therap
2021-006511-29: A Phase 2 study of PTC587 in patients with Amyotrophic Lateral Sclerosis

Not yet recruiting
2
258
Europe, RoW
PTC857 oral solution, PTC857, Oral solution
PTC Therapeutics, Inc., PTC THERAPEUTICS INC., PTC Therapeutics, Inc.
Amyotrophic Lateral Sclerosis (ALS), Amyotrophic Lateral Sclerosis is a type of Motor Neurone Disease. It is a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control., Diseases [C] - Nervous System Diseases [C10]
 
 
CARDINALS, NCT05349721: Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS

Active, not recruiting
2
307
Europe, Japan, US, RoW
PTC857, Placebo
PTC Therapeutics
Amyotrophic Lateral Sclerosis
09/24
03/27

Download Options